NERVOUS SYSTEM
NAME 3 MANIFESTATIONS OF BENZODIAZEPINE TOXICITY
* DROWSINESS
* LETHARGY
* CONFUSION
* RESPIRATORY DEPRESSION
* HYPOTENSION
(ATI Ch 6, Pg 45 "PAM/LAM")
PROPRANOLOL SHOULD BE AVOIDED IN PATIENTS THAT HAVE ________________
* ASTHMA
(ATI Ch 19, Pg 162)
WHAT HERBAL SUPPLEMENTS ARE CONTRAINDICATED WITH NSAID THERAPY
* GARLIC, GINGER, GINGKO BILOBA, ST JOHNS WORT, FEVERFEW
WHAT ARE 3 COMPLICATIONS OF LONG TERM CORTICOSTEROID USE
* IMMUNOSUPPRESSION
* HYPERGLYCEMIA
* BLEEDING
* OSTEOPOROSIS
* CATARACTS
* PEPTIC ULCERS
* WEIGHT GAIN D/T FLUID RETENTION
(ATI Ch 16, Pg 132-133)
* MACROLIDES: ERYTHROMYCIN, AZITHROMYCIN & CLARITHROMYCIN
(ATI CH 38, pgs. 327, 328 & 334)
NAME 2 MAJOR INTERACTIONS WHEN TAKING BUSPIRONE
* ST JOHNS WORT
* GRAPEFRUIT JUICE
(ATI Ch 6, Pg 46)
PROVIDE TEACHING POINTS FOR PATIENTS ON ENOXAPARIN THERAPY
* OBSERVE BLEEDING PRECAUTIONS
(COFFEE GROUND EMESIS, EPISTAXIS, TARRY STOOLS, ETC)
* ADMINISTER INJECTION SQ 2IN AWAY FROM UMBILICUS
* DO NOT MASSAGE INJECTION AREA
* DO NOT ASPIRATE BEFORE INJECTING
* DO NOT REMOVE THE BUBLE FROM THE PREFILLED SYRINGE
* AVOID NSAID AND OTC SUPPLEMENTS
(ATI Ch 22, Pg 187)
YOUR PATIENT HAS AN ORDER FOR MORPHINE 4MG IM EVERY 6 HOURS - UPON ASSESSMENT, YOU NOTE RESPIRATORY RATE IS 8/MIN - WHAT DO YOU DO?
* NOTIFY CHARGE NURSE/PROVIDER AND WITHOLD MEDICATION
* HAVE NALOXONE READY TO ADMINISTER
(ATI Ch 31, Pg 269-270)
WHAT IS THE RECOMMENDED VACCINE FOR CLIENT 65 YEARS OF AGE OR OLDER
* PNEUMOCOCCAL POLYSACCHARIDE VAX (PPSV23)
* PNEUMOCOCCAL CONJUGATE VAX (PCV15 & PCV20)
(ATI CH36, pg314)
ANTIMICROBIALS CAN HARM THE DEVELOPING FETUS (TERATOGENIC) BY CROSSING OVER THE PLACENTA, WHAT IS A COMPLETION OF ANTIMICROBIAL THERAPY IN PREGNANCY?
* SULFONAMIDE: CAN PRODUCE KERNICTERUS A SEVERE NEUROLOGIC DISORDER, IN NEWBORNS.
* GENTAMICIN: CAUSES HEARING LOSS IN INFANTS
* TETRACYCLINES: CASUES DISCOLORATION OF DEVELOPING TEETH.
(ATI CH 37, pg 324)
NAME 2 THERAPEUTIC USES OF BUPROPION
* SMOKING CESSATION
* S.A.D (SEASONAL AFFECTIVE DISORDER)
* ATTENTION DEFICIT DISORDER
* DEPRESSION
(ATI Ch 7, pg 54)
NAME 2 COMMON COMPLICATIONS FOR PATIENTS TAKING VERAPIMIL OR DILTIAZEM
* ORTHOSTATIC HYPOTENSION
* PERIPHERAL EDEMA
* SUPPRESSION OF CARDIAC FUNCTION
* ACUTE TOXICITY
* DYSRHYTHMIAS
NAME TWO THERAPEUTIC USES FOR CARBAMAZEPINE
* SEIZURES
* BIPOLAR DISORDER
* TRIGEMINAL & GLOSSOPHARYNGEAL NEURALGIAS
(ATI Ch 12, Pg 97)
IF A PATIENT IS ALLERGIC TO EGG, NEOMYCIN OR GELATIN THEY MAY ALSO BE ALLERGIC TO WHICH VACCINATIONS?
* INFLUENZA (EGG)
* MMR (EGG, NEOMYCIN, GELATIN)
* VARICELLA (NEOMYCIN, GELATIN)
(ATI Ch 36, Pg 316)
HOW WOULD YOU EVALUATE PATIENT UNDERSTANDING REGARDING CYCLOSPORINE THERAPY
* CLIENT STATES THEY WILL BE TAKING THIS MEDICATION FOR LIFE
* PATIENT STATES THEY WILL STAY AWAY FROM SICK PEOPLE
WHAT IS THE MAINTENANCE LEVEL OF LITHIUM
(ATI Ch 8, Pg 62)
* PLACE THE PATCH ON A HAIRLESS AREA ON SKIN OF UPPER TORSO
* LEAVE ON FOR 10-12 HOURS DURING THE DAY THEN OFF FOR 10 - 12 HOURS AT NIGHT
* ROTATE SITES
* DO NOT CUT PATCH
* FOLD INTO ITSELF WHEN REMOVING AND DISPOSE IN PROPER RECEPTACLE
(ATI ch 21, Pg 174)
YOUR PATIENT WAS RECENTLY GIVEN A PRESCRIPTION FOR SUMATRIPTAN - AS A NURSE, HOW WOULD YOU EVALUATE MEDICATION EFFECTIVENESS
* MIGRAINE REDUCTION / RELIEF OF HEADACHE
(ATI Ch 33, Pg 281)
WHAT ARE THE 2 MOST COMMON LIVE VACCINES
NAME 2 CONTRAINDICATIONS FOR LIVE VACCINES
* VARICELLA, MMR
* IMMUNOCOMPROMISED, PREGNANT, UNDER 12 MONTHS OF AGE
NAME 2 COMPLICATIONS FOR FLUROQUINOLONES (CIPROFLOXACIN)
* GI DISCOMFORT
* ACHILLES TENDON RUPTURE
* SUPRAINFECTION: THRUSH, VAGINAL YEAST INFECTION
* PHOTOTOXICITY
(ATI CH.40, pg341)
NAME 2 ADVERSE EFFECTS AND 1 INTERACTION OF LITHIUM
ADVERSE EFFECTS:
* GASTROINTESTINAL DISTRESS
* FINE HAND TREMORS
* POLYURIA
* WEIGHT GAIN
* GOITER & HYPOTHYROIDISM
INTERACTIONS:
* DIURETICS
* NSAIDS
* ANTICHOLINERGICS
(ATI Ch 8, Pg 61 - 62)
EXPLAIN WHY FUROSEMIDE INCREASES THE CHANCES FOR DIGOXIN TOXICITY
* FUROSEMIDE IS A LOOP DIURETIC - IT CAUSES LOSS OF POTASSIUM THROUGH URINE EXCRETION. HYPOKALEMIA IS A RISK FACTOR THAT CAN INCREASE THE TOXIC EFFECTS OF DIGOXIN
(ATI Ch 18, Pg 148) (ATI Ch 20, Pg 167)
NAME 2 COMPLICATIONS OF CELECOXIB THERAPY
* IMPAIRED KIDNEY FUNCTION
* INCREASED HEART ATTACK AND STROKE
* GI DISCOMFORT
* REYES SYNDROME
(ATI Ch 30, Pg 263)
NAME THE THREE GROWTH FACTORS
* Medications for erythropoietic growth factors: epoetin alfa
* Medications for thrombopoietic growth factors: oprelvekin
* Medications for leukopoietic growth factors: filgrastim
(ATI, CH 23, pg 197)
HOW WOULD YOU EVALUATE PATIENT UNDERSTANDING REGARDING ACYCOLVIR
* PATIENT STATES THAT THEY WILL SEE A RELIEF OF MANIFESTATIONS, BUT THAT THIS IS NOT A CURE.
(ATI CH 42, pg352)